Press release
7MM Digital Therapeutics for Diabetes Market Set for Strong Growth to US$ 2,578.46 Million by 2033, Led by North America's 45% Market Share | Key Players - Welldoc, Omada Health, Glooko
7MM Digital Therapeutics for Diabetes Market
Market growth is driven by the surging prevalence of diabetes worldwide, heightened demand for non-invasive glucose management solutions, and proven efficacy of digital therapeutics in improving patient adherence and outcomes. Advancements in AI-powered apps, wearable integrations for real-time monitoring, expanding reimbursement coverage, and rising investments in digital health platforms are further accelerating market expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/7mm-digital-therapeutics-for-diabetes-market?ram
Key Industry Developments
United States:
✅ January 2026: Medtronic Diabetes announced FDA clearance for the MiniMed Go smart MDI system, integrating insulin dosing and glucose data in a single app for simplified multiple daily injection therapy. This advancement provides automated insights and dosing recommendations, empowering users with type 1 and type 2 diabetes to manage their condition more confidently without guesswork.
✅ September 2025: Medtronic received FDA clearance for the MiniMed 780G system to integrate with Abbott's Instinct sensor, enhancing automated insulin delivery for people with diabetes. The update improves real-time glucose monitoring accuracy and expands compatibility, supporting better glycemic control in daily use.
Key Mergers and Acquisitions:
✅ Mitsubishi Tanabe Pharma acquired a domestic diabetes digital therapeutics company in May 2025, expanding remote care offerings and supporting R&D in personalized digital treatment for improved patient outcomes in Japan.
✅ Johnson & Johnson acquired a minority stake in a diabetes digital therapeutics company in May 2025, enhancing remote patient monitoring, R&D, and integration of digital care solutions to boost adherence across the 7MM.
✅ Roche partnered with a U.S. digital health startup in August 2025 to co-develop AI-enabled glucose management therapeutics, strengthening its digital health portfolio in the diabetes market.
✅ Sumitomo Pharma partnered with a U.S. digital therapeutics startup in August 2025 for AI-driven diabetes management solutions, focusing on adaptive therapy guidance to bolster Japan's digital health sector.
Key Players:
Welldoc, Inc. | Omada Health Inc. | Glooko, Inc. | Azumio Inc. | Abbott Laboratories | mySugr GmbH | Dexcom, Inc. | Health2Sync | iHealth Labs Inc. | Medtronic plc
Strategic Leadership Analysis: Top 5 Players in 7MM Digital Therapeutics for Diabetes Market 2026
-Welldoc, Inc.: Powered Lilly's new digital health platform for incretin therapies like Zepbound® and Mounjaro®, offering personalized support including medication reminders, dose tracking, health data logging, and customized digital coaching to manage type 2 diabetes and related cardiometabolic conditions.
-Glooko, Inc.: Launched interoperable solution with Hedia, combining connected care, remote patient monitoring, and digital therapeutic technologies to provide personalized insulin dosing advice for Type 1 and Type 2 diabetes patients on advanced bolus insulin, enhancing healthcare provider insights.
-Dexcom, Inc.: Introduced Dexcom G7 15 Day with overall MARD of 8.0%, the most accurate CGM, alongside new connectivity offerings and data showing long-term AID benefits, reduced severe hypoglycaemia, and HbA1c improvements for type 2 diabetes management.
-Medtronic plc: Announced FDA clearance and U.S. commercial launch of MiniMedTM 780G system with Instinct sensor and expanded sensor/insulin options, alongside MiniMed GoTM Smart MDI system, automating insulin delivery every five minutes for easier mealtimes and stable glucose control in type 1 and insulin-requiring type 2 diabetes.
-Health2Sync: Secured $20M in Series C funding to accelerate development of its first digital therapeutic product, integrating evidence-based practices with digital innovation for efficient blood glucose self-management, building on its platform serving over 1.2 million users worldwide.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=7mm-digital-therapeutics-for-diabetes-market?ram
Market Drivers and Key Trends:
-AI Personalization: AI-driven analytics in digital therapeutics process real-time glucose, diet, and activity data to deliver adaptive insulin dosing and lifestyle recommendations, enhancing glycemic control.
-Wearable Integration: Continuous Glucose Monitors (CGMs) paired with apps like Medtronic's Smart MDI and InPen enable seamless tracking and predictive alerts, reducing hypo/hyperglycemia risks.
-Patient Engagement Boost: Mobile platforms and telemedicine foster adherence through gamified coaching and remote monitoring, cutting hospitalizations amid rising diabetes prevalence in 7MM.
-Regulatory Momentum: FDA clearances for software solutions like Simplera CGM validate efficacy, accelerating provider trust and reimbursement in US, EU, and Japan.
-Cost Efficiency Focus: Evidence-based programs lower long-term healthcare spend by minimizing in-person visits and improving outcomes for type 1/2 diabetes management.
-Market Hurdles: Reimbursement variability, data privacy concerns, and integration challenges with legacy systems constrain widespread adoption despite tech advances.
Regional Insights:
-North America: 45% (Largest share, driven by advanced healthcare infrastructure and high adoption of CGM-integrated apps in the US).
-Europe: 30% (Strong growth from regulatory support like GDPR and investments in digital health across Germany, France, Italy, Spain, and UK).
-Japan: 25% (Emerging leader in Asia within 7MM, fueled by tech-savvy population and government-backed diabetes management initiatives).
Market Opportunities & Challenges: 7MM Digital Therapeutics for Diabetes Market 2026
-Opportunities: AI-driven personalization is accelerating adoption through real-time glucose insights and adaptive coaching; FDA-cleared integrations like Medtronic's Smart MDI system with InPen app and Simplera CGM enable seamless MDI therapy optimization. Rising smartphone penetration in Asia-Pacific markets like Japan and India supports scalable remote monitoring, while value-based pricing shifts favor software solutions for sustained patient engagement.
-Challenges: Data privacy regulations across EU GDPR and U.S. HIPAA frameworks complicate cross-border scalability, alongside reimbursement gaps in emerging 7MM regions that hinder broad health system integration. Digital literacy barriers among aging diabetes populations demand targeted clinician training to boost uptake.
-Strategic Verdict: AI-powered software platforms and CGM-insulin pen hybrids are the core growth drivers for 2026.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/7mm-digital-therapeutics-for-diabetes-market?ram
Market Segmentation Analysis:
-By Product Type: Software Dominates Digital Therapeutics
Software holds the largest share at 70% in 2024, powering app-based glucose monitoring, personalized coaching, and behavioral interventions for diabetes self-management.
Combined software-hardware solutions capture 20%, integrating wearables like CGMs for real-time data syncing and automated insights.
Hardware-only devices, such as smart insulin pens, account for 10%, valued for precise dosing but limited by standalone functionality.
-By Application: Type 2 Diabetes Leads with Prevalence
Type 2 diabetes commands 60% market share, driven by its 90%+ prevalence among 500M+ global cases needing lifestyle and adherence tools.
Type 1 diabetes follows at 30%, focusing on insulin optimization amid tech-savvy users.
Gestational diabetes takes 10%, targeting pregnancy-specific monitoring.
-By End User: Patients Dominate Home Use
Patients lead with 55% share, embracing direct-to-consumer apps for daily empowerment.
Healthcare providers hold 30%, using platforms for remote monitoring in clinics.
Payers/insurers account for 15%, adopting for cost-saving population health programs.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 7MM Digital Therapeutics for Diabetes Market Set for Strong Growth to US$ 2,578.46 Million by 2033, Led by North America's 45% Market Share | Key Players - Welldoc, Omada Health, Glooko here
News-ID: 4401386 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Digital Health & AI Tools in Neuroscience Market Set for Strong Growth to US$ 79 …
The global Digital Health & AI tools in Neuroscience Market size reached US$ 31.25 billion with rise of US$ 34.10 billion in 2024 and is expected to reach US$ 79.30 billion by 2033, growing at a CAGR of 9.9% during the forecast period 2025-2033.
Market growth is driven by the increasing prevalence of neurological disorders like Alzheimer's and Parkinson's, rising adoption of AI-powered diagnostics and telemedicine, and strong clinical outcomes from…
Wound Closure Products Market to Reach US$ 41.76 Billion by 2033 at 5.5% CAGR; N …
The Wound Closure Products Market reached US$ 24.23 billion in 2023 and increased to US$ 25.49 billion in 2024. The market is projected to reach US$ 41.76 billion by 2033, growing at a CAGR of 5.5 percent during the forecast period 2025 to 2033. Market growth is driven by the rising number of surgical procedures, increasing prevalence of chronic wounds, and growing incidence of trauma and accident related injuries worldwide.
Wound…
Neurostimulation Devices Market to Reach US$ 17.82 Billion by 2033 at 11.1% CAGR …
The Neurostimulation Devices Market reached US$ 6.99 billion in 2024, up from US$ 6.36 billion in 2023, and is projected to reach US$ 17.82 billion by 2033, growing at a CAGR of 11.1 percent during the forecast period 2025 to 2033. Market growth is driven by the increasing prevalence of neurological disorders, rising incidence of chronic pain conditions, and growing adoption of minimally invasive treatment alternatives.
Neurostimulation devices deliver targeted electrical…
Master Data Management Market Set for Explosive Growth to US$ 90.26 Billion by 2 …
The Master Data Management Market reached US$ 22.03 billion in 2024 and is expected to reach US$ 90.26 billion by 2034, growing at a robust CAGR of 15% during the forecast period 2025-2034.
Market growth is driven by the increasing demand for unified enterprise‐grade data platforms, rising need for regulatory compliance and data‐governance frameworks, and the growing adoption of cloud‐based MDM solutions across BFSI, healthcare, retail, and manufacturing sectors. Advancements in…
More Releases for Digital
Digital luxury brands Market Is Booming Worldwide | Major Giants Balenciaga Digi …
HTF MI recently introduced Global Digital luxury brands Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence.
Major companies in Digital luxury brands Market are:
Balenciaga Digital, Louis Vuitton Digital, Gucci Digital, Dolce & Gabbana DGFamily, Prada Virtual,…
Introducing Digital Sales Pro, Inc: Revolutionizing Digital Sales in the Digital …
Digital Sales Pro, Inc. is a company that helps content creators and publishers make money from content and reach a larger audience with their craft.
In today's world, it can be tough for content creators and publishers to make money and connect with their audience.
At, Digital Sales Pro, Inc. we understand these challenges and have created a suite of solutions that help our clients build a strong online presence, monetize…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
Introduction
The healthcare industry has seen significant growth and development over the years, with technology playing a critical role in transforming patient care. One such innovative technology that has emerged in recent years is the Global Digital Twin in Healthcare Market. This technology allows healthcare professionals to create a virtual replica of a patient's physical self, enabling them to monitor and analyze patient data in real-time. The Global Digital Twin in…
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
In 2021, the market for Digital Twin in Healthcare worldwide was worth $6.75 billion US dollars. AMR Group projects that the market will reach US$ 96.5 billion by 2031, growing at a CAGR of 40 percent between 2022 and 2031.
Industry Overview
Digital twins are virtual copies of physical objects or things that data scientist & IT professionals can use to compute simulations prior to developing and deploying the original devices. Digital…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Digital Display Market Future Growth with Worldwide Players (Digital Virgo, Digi …
Digital Display Industry 2019 Global Market 2025 research report represents the historical overview of current Market situation, size, share, trends, growth, supply, outlook and manufacturers with detailed analysis. It also focuses on Digital Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Display market size by analyzing historical data and future prospect.
Get Sample Copy of this Report -…
